COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis
Borges et al. have recently reported the first case of a dermatomyositis onset in close association with established coronavirus disease 2019 (COVID-19). Similarly, we report a patient who, on the contrary, had COVID-19 following early established dermatomyositis. We report prospectively the outcom...
Main Authors: | M.S.M.S. Faria, S.K. Shinjo |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-05-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | https://www.reumatismo.org/index.php/reuma/article/view/1440 |
Similar Items
-
The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
by: Vanessa Posener de Andrade, et al.
Published: (2021-02-01) -
Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review
by: C.G.V. de Carvalho, et al.
Published: (2024-10-01) -
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
by: Anaïs Nombel, et al.
Published: (2021-10-01) -
Clinical and autoantibody phenotypes of juvenile dermatomyositis
by: Oksana Boyarchuk, et al.
Published: (2022-08-01) -
Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)